You Searched For: TOSOH+Bioscience
490 results were found
A18L14A UHP SEC analysis of biosimilars
/m-cz.vwr.com/cs_CZ/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-dk.vwr.com/da_DK/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~A18L14A UHP SEC analysis of biosimilars~~
/m-in.vwr.com/en_IN/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/de_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~A18L14A UHP SEC analysis of biosimilars~~
/m-cn.vwr.com/zh_CN/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
~~A18L14A UHP SEC analysis of biosimilars~~
/it.vwr.com/it_IT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-se.vwr.com/sv_SE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/fr_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-it.vwr.com/it_IT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-pt.vwr.com/pt_PT/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-kr.vwr.com/ko_KR/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ie.vwr.com/en_IE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-hu.vwr.com/hu_HU/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ch.vwr.com/it_CH/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
Hichrom International Catalogue 9 33 57
/m-es.vwr.com/es_ES/images/Hichrom_International_Catalogue_9_33_57.pdf
33 LC Colum n Selection – C18 Reversed-Phase M aterials www.hichrom.co.uk • sales@hichrom.co.uk • Tel: +44 (0) 118 930 3660 Hichrom Lim ited C18 Reversed-Phase Materials SPECIFICATIONS OF C18 BONDED RP MATERIALS Octadecyl (ODS) or C18 bonded phase...
161 - 176 of 490